1.14.14.55: quinine 3-monooxygenase
This is an abbreviated version!
For detailed information about quinine 3-monooxygenase, go to the full flat file.
Word Map on EC 1.14.14.55
-
1.14.14.55
-
cyp2d6
-
cyp1a2
-
drug-drug
-
hepatocytes
-
midazolam
-
ketoconazole
-
p-glycoprotein
-
dosing
-
xenobiotics
-
drug-metabolizing
-
concentration-time
-
clopidogrel
-
testosterone
-
disposition
-
interindividual
-
pharmacodynamics
-
pharmacogenetic
-
pregnane
-
omeprazole
-
coadministration
-
rifampicin
-
antiplatelet
-
erythromycin
-
open-label
-
dextromethorphan
-
phenobarbital
-
tacrolimus
-
ritonavir
-
coadministered
-
n-demethylation
-
itraconazole
-
grapefruit
-
tolbutamide
-
quinidine
-
first-pass
-
warfarin
-
carbamazepine
-
androstane
-
phenytoin
-
clarithromycin
-
voriconazole
-
pharmacogenomics
-
methadone
-
p450-mediated
-
infinity
-
ugt2b7
-
efavirenz
-
ugt1a1
-
vkorc1
-
saquinavir
-
medicine
- 1.14.14.55
- cyp2d6
- cyp1a2
-
drug-drug
- hepatocytes
- midazolam
- ketoconazole
- p-glycoprotein
-
dosing
- xenobiotics
-
drug-metabolizing
-
concentration-time
- clopidogrel
- testosterone
-
disposition
-
interindividual
-
pharmacodynamics
-
pharmacogenetic
-
pregnane
- omeprazole
-
coadministration
- rifampicin
-
antiplatelet
- erythromycin
-
open-label
- dextromethorphan
- phenobarbital
- tacrolimus
- ritonavir
-
coadministered
-
n-demethylation
- itraconazole
- grapefruit
- tolbutamide
- quinidine
-
first-pass
- warfarin
- carbamazepine
-
androstane
- phenytoin
- clarithromycin
- voriconazole
-
pharmacogenomics
- methadone
-
p450-mediated
-
infinity
- ugt2b7
- efavirenz
- ugt1a1
- vkorc1
- saquinavir
- medicine
Reaction
Synonyms
CYP2C19, CYP3A, CYP3A4, CYPIIIA4, cytochrome P450 isoform, EC 1.14.13.67, NF-25, Nifedipine oxidase, P450-PCN1, quinine 3-hydroxylase, Quinine 3-monooxygenase, quinine monooxygenase
ECTree
Advanced search results
Application
Application on EC 1.14.14.55 - quinine 3-monooxygenase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
medicine
green tea extract use may cause significant interactions with drugs metabolized by CYP3A4. Effect on CYP3A4 varies among different brands of green tea extract, possibly due to variations in their content of the herbal product's active ingredients
medicine
plasma concentration of 4beta-hydroxycholesterol may be used as an endogenous marker of CYP3A activity